Nitish Mehta

1 week ago | europe.ophthalmologytimes.com | Martin Harp |Hattie Hayes |Nitish Mehta

Editors from the Eye Care Network are onsite at this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah. During the conference, we spoke with Nitish Mehta, MD, an assistant professor at New York University Langone Health in New York, NY. He shared highlights from his research, which documented real-world results of aflibercept 8 mg for patients with diabetic macular oedema (DMO).